Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib.

导出 LinkOut

翻译打印收藏纠错

作者： Rudolf,Letkemann ^[1] ; Helmut,Wittkowski ^[2] ; Aristotelis,Antonopoulos ^[3] ; Teodor,Podskabi ^[4] ; Stuart M,Haslam ^[5] ; Dirk,Föll ^[6] ; Anne,Dell ^[7] ; Thorsten,Marquardt ^[8]

作者单位： Department of General Pediatrics, Metabolic Diseases, University Children's Hospital Muenster, Germany. Electronic address: r.letkemann@uni-muenster.de. ^[1] Department of Pediatric Rheumatology and Imunology, University Children's Hospital Muenster, Germany. Electronic address: helmut.wittkowski@ukmuenster.de. ^[2] Department of Life Sciences, Imperial College London, SW7 2AZ, UK. Electronic address: a.antonopoulos@imperial.ac.uk. ^[3] Molecular Genetics and Metabolism Laboratory, Munich, Germany. Electronic address: metabolic-genetic-disease@gmx.de. ^[4] Department of Life Sciences, Imperial College London, SW7 2AZ, UK. Electronic address: s.haslam@imperial.ac.uk. ^[5] Department of Pediatric Rheumatology and Imunology, University Children's Hospital Muenster, Germany. Electronic address: dfoell@uni-muenster.de. ^[6] Department of Life Sciences, Imperial College London, SW7 2AZ, UK. Electronic address: a.dell@imperial.ac.uk. ^[7] Department of General Pediatrics, Metabolic Diseases, University Children's Hospital Muenster, Germany. Electronic address: marquat@uni-muenster.de. ^[8]

关键词 CDG Galactose Glycogen storage disease Glycosylation Neutrophil dysfunction